Table 2 Fecal microbiota at 0, 8 and 16 weeks in diabetic patients with and without probiotic administration.

From: Probiotic reduces bacterial translocation in type 2 diabetes mellitus: A randomised controlled study

 

0 weeks

8 weeks

16 weeks

Control

Probiotic

Control

Probiotic

Control

Probiotic

Total bacteria

10.2 ± 0.6

(100.0)

10.3 ± 0.6

(100.0)

10.2 ± 0.5

(100.0)

10.3 ± 0.5

(100.0)

10.2 ± 0.6

(100.0)

10.4 ± 0.4

(100.0)

Obligate anaerobes

C. coccoides group

9.4 ± 0.7

(100.0)

9.5 ± 0.8

(100.0)

9.3 ± 0.6

(100.0)

9.6 ± 0.5

(100.0)

9.5 ± 0.6

(97.1)

9.8 ± 0.4*

(100.0)

C. leptum subgroup

9.5 ± 0.8

(100.0)

9.6 ± 0.7

(100.0)

9.4 ± 0.8

(100.0)

9.5 ± 0.7

(100.0)

9.4 ± 0.8

(100.0)

9.8 ± 0.5*

(100.0)

Bacteroides fragilis group

8.7 ± 0.7

(100.0)

8.8 ± 0.8

(100.0)

8.6 ± 0.6

(94.1)

8.6 ± 0.7

(100.0)

8.6 ± 0.6

(97.1)

8.8 ± 0.7

(100.0)

Bifidobacterium

8.7 ± 1.0

(97.1)

8.9 ± 1.3

(100.0)

8.9 ± 1.1

(97.1)

8.8 ± 1.2

(100.0)

9.0 ± 1.1$

(100.0)

9.0 ± 1.0

(97.1)

Atopobium cluster

9.2 ± 0.9

(100.0)

9.3 ± 0.6

(100.0)

9.3 ± 0.8

(97.1)

9.4 ± 0.5

(100.0)

9.4 ± 0.8$

(97.1)

9.5 ± 0.6

(100.0)

Prevotella

8.7 ± 1.2

(47.1)

7.7 ± 1.5

(64.7)

8.2 ± 1.7

(55.9)

8.2 ± 1.4

(61.8)

8.3 ± 1.6$

(64.7)

8.0 ± 1.6

(70.6)

Akkermansia muciniphila

7.4 ± 1.1

(64.7)

7.4 ± 1.6

(64.7)

7.6 ± 1.4

(61.8)

7.3 ± 1.5

(64.7)

7.5 ± 1.2

(67.6)

7.9 ± 1.6

(61.8)

C. difficle

4.7 ± 1.8

(8.8)

<2.3

(0.0)

3.9 ± 1.0

(11.8)

4.3 ± 1.3

(11.8)

3.6 ± 0.6

(17.6)

3.7 ± 1.2

(14.7)

C. perfringens

4.8 ± 1.2

(26.5)

5.2 ± 1.8

(35.3)

4.7 ± 2.0

(32.4)

5.4 ± 1.8

(26.5)

4.6 ± 1.4

(41.2)

4.6 ± 1.1

(26.5)

Facultative anaerobes

Total Lactobacillus

6.2 ± 1.5

(100.0)

5.7 ± 1.2

(100.0)

6.2 ± 1.6

(100.0)

7.6 ± 0.6**$$

(100.0)

6.7 ± 1.4$

(100.0)

7.7 ± 0.6**$$

(100.0)

L. gasseri subgroup

5.8 ± 1.6

(76.5)

5.1 ± 1.2

(85.3)

5.6 ± 1.7

(85.3)

5.5 ± 1.1$

(82.4)

5.8 ± 1.4

(88.2)

5.6 ± 1.1$

(79.4)

L. brevis

4.8 ± 1.5

(38.2)

4.0 ± 0.6

(23.5)

3.8 ± 0.9

(29.4)

3.7 ± 1.0

(38.2)

4.3 ± 1.4

(38.2)

4.2 ± 1.1

(29.4)

L. casei subgroup

5.0 ± 1.2

(41.2)

4.9 ± 1.1

(29.4)

4.6 ± 0.7

(38.2)

7.4 ± 0.7** $$

(100.0)**

5.0 ± 1.3

(38.2)

7.4 ± 0.8**$$

(100.0)**

L. fermentum

5.9 ± 1.1

(29.4)

6.0 ± 1.2

(35.3)

6.4 ± 1.3

(32.4)

5.6 ± 1.1

(38.2)

6.7 ± 1.1$

(41.2)

6.1 ± 1.1

(38.2)

L. fructivorans

4.5 ± 1.0

(14.7)

3.3 ± 1.3

(8.8)

3.3 ± 0.3

(5.9)

3.5 ± 0.8

(8.8)

<2.3

(0.0)

4.9

(2.9)

L. plantarum subgroup

4.7 ± 1.6

(76.5)

4.4 ± 1.0

(88.2)

4.2 ± 1.2

(79.4)

4.3 ± 1.0

(85.3)

4.5 ± 1.3

(70.6)

4.3 ± 1.0

(85.3)

L. reuteri subgroup

5.2 ± 1.5

(61.8)

4.8 ± 1.0

(76.5)

5.5 ± 1.3

(67.6)

4.9 ± 1.2

(79.4)

5.5 ± 1.5

(70.6)

5.3 ± 1.0$

(76.5)

L. ruminis subgroup

4.9 ± 1.6

(61.8)

5.0 ± 1.7

(50.0)

5.7 ± 1.8

(52.9)

5.3 ± 1.5

(61.8)

5.1 ± 1.9

(61.8)

4.9 ± 2.0

(67.6)

L. sakei subgroup

4.6 ± 1.7

(38.2)

4.2 ± 0.8

(23.5)

4.8 ± 1.3

(44.1)

5.1 ± 1.2

(32.4)

5.4 ± 1.7

(47.1)

4.5 ± 1.8

(29.4)

Enterobacteriaceae

7.1 ± 1.3

(91.2)

7.1 ± 1.2

(97.1)

6.9 ± 0.9$

(85.3)

7.0 ± 1.2

(91.2

6.9 ± 1.0

(73.5)

7.0 ± 0.9

(85.3)

Enterococcus

6.3 ± 1.3

(88.2)

6.0 ± 1.3

(85.3)

6.2 ± 1.0

(82.4)

6.2 ± 1.2

(82.4)

6.0 ± 1.3

(82.4)

6.5 ± 1.2$

(76.5)

Streptococcus

8.4 ± 1.1

(100.0)

8.5 ± 0.8

(100.0)

8.4 ± 0.9

(97.1)

8.3 ± 0.6

(100.0)

8.4 ± 1.3

(97.1)

8.5 ± 0.8

(100.0)

Staphylococcus

4.7 ± 1.0

(85.3)

4.7 ± 0.8

(91.2)

4.4 ± 0.8$

(91.2)

4.4 ± 0.8

(94.1)

4.5 ± 0.9

(73.5)

4.4 ± 0.7

(91.2)

Aerobes

Pseudomonas

4.7 ± 1.9

(17.6)

3.7 ± 0.8

(23.5)

4.2 ± 0.8

(23.5)

4.5 ± 0.7

(23.5)

3.9 ± 1.0

(26.5)

4.6 ± 0.7

(26.5)

Administration of L. casei strain Shirota

<5.0

(0.0)

5.8

(2.9)

<5.0

(0.0)

7.3 ± 0.8

(97.1)**

6.4

(2.9)

7.2 ± 0.8

(91.2)**

  1. $ p < 0.05 vs. baseline, $$ p < 0.01 vs. baseline, *p < 0.05 vs. Control, **p < 0.01 vs. Control.
  2. The results are expressed as mean ± SD (log10 cells/g of feces). Detection rate (%).